Merck Stock News

Chesley Taft & Associates LLC grew its holdings in shares of Merck & Co., Inc. (NYSE:MRK) by 0.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 57,510 shares of the companys stock after buying an additional 250 shares during the period. Chesley Taft & Associates []

The global TNF inhibitors market was valued around US$ 40,369.8 Mn in 2017. It is anticipated to expand at a stable CAGR of 2.54% during the forecast period of 2018 to 2026, according to a new report published by Transparency

The new drugs, which unlike vaccines can be used to treat patients once they contract coronavirus infection, are expected to be a huge market.

Iovance Biotherapeutics Inc (NASDAQ: IOVA ) has announced data for lifileucel in combination with Merck Co Inc''s (NYSE: MRK ) Keytruda (pembrolizumab) in patients with advanced cancers. Data were presented at the Society for Immunotherapy of Cancer Annual Meeting. Early-line treatment with single-agent pembrolizumab achieved an overall Full story available on Benzinga.com

Global Veterinary Antimicrobial Susceptibility Testing Market Synopsis: The finest Veterinary Antimicrobial Susceptibility Testing Market analysis document enumerates information about the key companies based on their Market position in the present scenario along with data related to the Market sales gathered by

Woodstock Corp raised its holdings in Merck & Co., Inc. (NYSE:MRK) by 0.7% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 126,271 shares of the companys stock after acquiring an additional 896 shares during the period. Woodstock Corps holdings in Merck & Co., Inc. were worth $9,484,000 at the end of the []

Multiple Sclerosis Market is the most relevant, unique, fair and creditable global market research report which is provided to the valuable customers and clients depending upon their specific business needs. The report endows with complete market analysis and forecasting, market

Protein Expression market is expected to witness market growth at a rate of 11.6% in the forecast period of 2021 to 2028. Data Bridge Market Research report on protein expression market provides analysis and insights regarding the various factors expected

The HER2 Inhibitors report published by Data Bridge Market research is the representation of data and analysis of the market. It gives detailed analysis of the current market scenario and a market forecast till 2028. The data included

The Global "Cancer Cachexia Market" 2021-2024 research report is a professional and in-depth study on the current state of the Cancer Cachexia industry. It provides key analysis on the market status of the Cancer Cachexia manufacturers with best-in-class facts and

Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players Key Companies in Parkinsons Disease Drugs Market are Pfizer, Roche, Merck, Novartis, Orion Pharma, UCB, Teva Pharmaceutical, Vertical Pharmaceuticals, ACADIA Pharmaceuticals Inc., Impax Laboratories, Lundbeck and Others Key Players

Animal Parasiticides Market research report is a complete overview of the market, covering various aspects like the product definition, segmentation based on various parameters, and the prevailing vendor landscape. the industry is anticipated to witness higher growth during the forecast

NEW DELHI, India: The Merck drug, Molnupiravir, an antiviral pill that treats mild-to-moderate COVID-19 cases, could be given emergency authorization use "within days" in India, according to Dr. Ram Vishwakarma, Chairman of the Covid Strategy Group, as quoted by New Delhi TV. He added that the drug is for use by adults who are at risk of severe COVID-19 or hospitalization. Another Covid pill developed by

Newbridge Financial Services Group Inc. grew its position in shares of Merck & Co., Inc. (NYSE:MRK) by 14.3% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,629 shares of the companys stock after acquiring an additional 204 shares during the period. Newbridge Financial Services Group Inc.s holdings in Merck & Co., Inc. were worth []

Indiana Trust & Investment Management CO boosted its holdings in Merck & Co., Inc. (NYSE:MRK) by 3.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 4,902 shares of the companys stock after buying an additional 153 shares during the period. Indiana Trust & Investment Management COs holdings []